Nurix Therapeutics, Inc.
NRIX · NASDAQ
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $110 | $55 | $64 | $81 |
| Short-Term Investments | $500 | $233 | $245 | $215 |
| Receivables | $2 | $1 | $1 | $6 |
| Inventory | $0 | $0 | -$1 | $0 |
| Other Curr. Assets | $8 | $7 | $9 | $9 |
| Total Curr. Assets | $619 | $296 | $318 | $311 |
| Property Plant & Equip (Net) | $46 | $48 | $30 | $25 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $7 | $64 | $137 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $5 | $5 | $3 |
| Total NC Assets | $50 | $60 | $98 | $166 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $669 | $356 | $417 | $477 |
| Liabilities | – | – | – | – |
| Payables | $11 | $6 | $5 | $7 |
| Short-Term Debt | $8 | $7 | $6 | $4 |
| Tax Payable | $1 | $0 | $0 | $0 |
| Deferred Revenue | $38 | $48 | $38 | $41 |
| Other Curr. Liab. | $37 | $25 | $22 | $15 |
| Total Curr. Liab. | $96 | $87 | $71 | $66 |
| LT Debt | $20 | $23 | $6 | $9 |
| Deferred Rev, NC | $26 | $45 | $36 | $59 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $46 | $68 | $42 | $68 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $28 | $23 | $6 | $9 |
| Total Liabilities | $142 | $155 | $113 | $134 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$739 | -$545 | -$401 | -$221 |
| AOCI | $0 | -$1 | -$4 | -$1 |
| Other Equity | $1,266 | $746 | $709 | $564 |
| Total Equity | $527 | $200 | $304 | $342 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $669 | $356 | $417 | $477 |
| Net Debt | -$82 | -$24 | -$53 | -$67 |